199 related articles for article (PubMed ID: 29699493)
1. Effects of age, comorbidity and adherence to current antimicrobial guidelines on mortality in hospitalized elderly patients with community-acquired pneumonia.
Han X; Zhou F; Li H; Xing X; Chen L; Wang Y; Zhang C; Liu X; Suo L; Wang J; Yu G; Wang G; Yao X; Yu H; Wang L; Liu M; Xue C; Liu B; Zhu X; Li Y; Xiao Y; Cui X; Li L; Purdy JE; Cao B;
BMC Infect Dis; 2018 Apr; 18(1):192. PubMed ID: 29699493
[TBL] [Abstract][Full Text] [Related]
2. Improving outcomes in elderly patients with community-acquired pneumonia by adhering to national guidelines: Community-Acquired Pneumonia Organization International cohort study results.
Arnold FW; LaJoie AS; Brock GN; Peyrani P; Rello J; Menéndez R; Lopardo G; Torres A; Rossi P; Ramirez JA;
Arch Intern Med; 2009 Sep; 169(16):1515-24. PubMed ID: 19752410
[TBL] [Abstract][Full Text] [Related]
3. The impact of empiric antimicrobial therapy with a β-lactam and fluoroquinolone on mortality for patients hospitalized with severe pneumonia.
Mortensen EM; Restrepo MI; Anzueto A; Pugh J
Crit Care; 2005 Dec; 10(1):R8. PubMed ID: 16420641
[TBL] [Abstract][Full Text] [Related]
4. Atypical coverage in community-acquired pneumonia after outpatient beta-lactam monotherapy.
van Werkhoven CH; van de Garde EMW; Oosterheert JJ; Postma DF; Bonten MJM
Respir Med; 2017 Aug; 129():145-151. PubMed ID: 28732822
[TBL] [Abstract][Full Text] [Related]
5. Effect of β-Lactam Plus Macrolide Versus Fluoroquinolone on 30-Day Readmissions for Community-Acquired Pneumonia.
Gilbert TT; Arfstrom RJ; Mihalovic SW; Dababneh AS; Varatharaj Palraj BR; Dierkhising RA; Mara KC; Lessard SR
Am J Ther; 2020; 27(2):e177-e182. PubMed ID: 30418221
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic treatment outcomes in community-acquired pneumonia.
Çilli A; Sayıner A; Çelenk B; Şakar Coşkun A; Kılınç O; Hazar A; Aktaş Samur A; Taşbakan S; Waterer GW; Havlucu Y; Kılıç Ö; Tokgöz F; Bilge U
Turk J Med Sci; 2018 Aug; 48(4):730-736. PubMed ID: 30119147
[TBL] [Abstract][Full Text] [Related]
7. How good is the evidence for the recommended empirical antimicrobial treatment of patients hospitalized because of community-acquired pneumonia? A systematic review.
Oosterheert JJ; Bonten MJ; Hak E; Schneider MM; Hoepelman IM
J Antimicrob Chemother; 2003 Oct; 52(4):555-63. PubMed ID: 12972448
[TBL] [Abstract][Full Text] [Related]
8. Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit.
Frei CR; Attridge RT; Mortensen EM; Restrepo MI; Yu Y; Oramasionwu CU; Ruiz JL; Burgess DS
Clin Ther; 2010 Feb; 32(2):293-9. PubMed ID: 20206787
[TBL] [Abstract][Full Text] [Related]
9. Disease burden and prognostic factors for clinical failure in elderly community acquired pneumonia patients.
Han X; Liu X; Chen L; Wang Y; Li H; Zhou F; Xing X; Zhang C; Suo L; Wang J; Yu G; Wang G; Yao X; Yu H; Wang L; Liu M; Xue C; Liu B; Zhu X; Li Y; Xiao Y; Cui X; Li L; Cao B;
BMC Infect Dis; 2020 Sep; 20(1):668. PubMed ID: 32919458
[TBL] [Abstract][Full Text] [Related]
10. Empiric treatment in hospitalized community-acquired pneumonia. Impact on mortality, length of stay and re-admission.
Reyes Calzada S; Martínez Tomas R; Cremades Romero MJ; Martínez Moragón E; Soler Cataluña JJ; Menéndez Villanueva R
Respir Med; 2007 Sep; 101(9):1909-15. PubMed ID: 17628462
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic treatment strategies for community-acquired pneumonia in adults.
Postma DF; van Werkhoven CH; van Elden LJ; Thijsen SF; Hoepelman AI; Kluytmans JA; Boersma WG; Compaijen CJ; van der Wall E; Prins JM; Oosterheert JJ; Bonten MJ;
N Engl J Med; 2015 Apr; 372(14):1312-23. PubMed ID: 25830421
[TBL] [Abstract][Full Text] [Related]
12. Impact of atypical coverage for patients with community-acquired pneumonia managed on the medical ward: results from the United States Community-Acquired Pneumonia Project.
Frei CR; Koeller JM; Burgess DS; Talbert RL; Johnsrud MT
Pharmacotherapy; 2003 Sep; 23(9):1167-74. PubMed ID: 14524648
[TBL] [Abstract][Full Text] [Related]
13. Cardiac events after macrolides or fluoroquinolones in patients hospitalized for community-acquired pneumonia: post-hoc analysis of a cluster-randomized trial.
Postma DF; Spitoni C; van Werkhoven CH; van Elden LJR; Oosterheert JJ; Bonten MJM
BMC Infect Dis; 2019 Jan; 19(1):17. PubMed ID: 30612559
[TBL] [Abstract][Full Text] [Related]
14. Cost effectiveness of adherence to IDSA/ATS guidelines in elderly patients hospitalized for Community-Aquired Pneumonia.
Egger ME; Myers JA; Arnold FW; Pass LA; Ramirez JA; Brock GN
BMC Med Inform Decis Mak; 2016 Mar; 16():34. PubMed ID: 26976388
[TBL] [Abstract][Full Text] [Related]
15. The science of selecting antimicrobials for community-acquired pneumonia (CAP).
File TM
J Manag Care Pharm; 2009 Mar; 15(2 Suppl):S5-11. PubMed ID: 19236135
[TBL] [Abstract][Full Text] [Related]
16. Severe community-acquired pneumonia in general medical wards: outcomes and impact of initial antibiotic selection.
Wongsurakiat P; Chitwarakorn N
BMC Pulm Med; 2019 Oct; 19(1):179. PubMed ID: 31619219
[TBL] [Abstract][Full Text] [Related]
17. Adherence to guidelines for hospitalized community-acquired pneumonia over time and its impact on health outcomes and mortality.
Costantini E; Allara E; Patrucco F; Faggiano F; Hamid F; Balbo PE
Intern Emerg Med; 2016 Oct; 11(7):929-40. PubMed ID: 27098057
[TBL] [Abstract][Full Text] [Related]
18. Coverage of atypical pathogens for hospitalised patients with community-acquired pneumonia is not guided by clinical parameters.
Piso RJ; Arnold C; Bassetti S
Swiss Med Wkly; 2013; 143():w13870. PubMed ID: 24089030
[TBL] [Abstract][Full Text] [Related]
19. Comparison of beta-lactam and macrolide combination therapy versus fluoroquinolone monotherapy in hospitalized Veterans Affairs patients with community-acquired pneumonia.
Lodise TP; Kwa A; Cosler L; Gupta R; Smith RP
Antimicrob Agents Chemother; 2007 Nov; 51(11):3977-82. PubMed ID: 17709460
[TBL] [Abstract][Full Text] [Related]
20. Elderly patients with community-acquired pneumonia: optimal treatment strategies.
Thiem U; Heppner HJ; Pientka L
Drugs Aging; 2011 Jul; 28(7):519-37. PubMed ID: 21721597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
